W.R. Berkley Corp’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

W.R. Berkley Corp’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-24,701	Closed	-$835K	–	519
2021 Q2	$835K	Buy	+24,701	New	+$629K	0.08%	199

W.R. Berkley Corp's CNST Position: Q3 2021 in Review

W.R. Berkley Corp sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 24,701 shares — an estimated $835K sold.

W.R. Berkley Corp first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $835K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

W.R. Berkley Corp reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
W.R. Berkley Corp sold 24,701 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $835K.
W.R. Berkley Corp first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
W.R. Berkley Corp's Constellation Pharmaceuticals, Inc. position peaked at $835K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on W.R. Berkley Corp's 13F filing for Q3 2021, filed 15 Nov 2021.